The CRI specializes in manufacturing protein and immunotoxin therapeutics for phase I clinical trials. We help our clients advance novel agents through the product pipeline from the earliest stages of drug development. Numerous investigators, from academia and foundations to start-ups and mid-sized companies, bring their discoveries to us to complete the next steps for introducing new treatments to the clinic.
The journey to the clinic is a long one. Let us help you with the first step.
For more information:
Realizing Your Ideas. That's What We Do.
Ultimately, our clients receive all standard operating procedures, batch records and the master drug files associated with drug production, in addition to a complete chemistry manufacturing and control (CMC) section ready for your investigational new drug application. We also work with any future collaborators to ensure a smooth transition to phase II/III or commercial production.